• Citer

Clinical experience with the European ankylosing spondylitis infliximab cohort (EASIC): Long-term extension over 7 years with focus on clinical efficacy and safety

par Heldmann, Frank;de Vlam, Kurt;Gaston, Hill;Gruenke, Mathias;Witt, Mathias;Appelboom, Thierry ;Emery, Paul;Dougados, Maxime;Leirisalo-Repo, Marjatta;Bréban, Maxime;Braun, Jürgen;Baraliakos, Xenofon;Kiltz, Uta;Brandt, Jan;van der Horst-Bruinsma, Irene I.E.;Landewe, Robert;Sieper, Joachim;Burmester, Gert Rüdiger;Van Den Bosch, Filip
Référence Clinical and Experimental Rheumatology, 34, 2, page (184-190)
Publication Publié, 2016-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Clinical experience with the European ankylosing spondylitis infliximab cohort (EASIC): Long-term extension over 7 years with focus on clinical efficacy and safety
Auteur:	Heldmann, Frank; de Vlam, Kurt; Gaston, Hill; Gruenke, Mathias; Witt, Mathias; Appelboom, Thierry; Emery, Paul; Dougados, Maxime; Leirisalo-Repo, Marjatta; Bréban, Maxime; Braun, Jürgen; Baraliakos, Xenofon; Kiltz, Uta; Brandt, Jan; van der Horst-Bruinsma, Irene I.E.; Landewe, Robert; Sieper, Joachim; Burmester, Gert Rüdiger; Van Den Bosch, Filip
Informations sur la publication:	Clinical and Experimental Rheumatology, 34, 2, page (184-190)
Statut de publication:	Publié, 2016-03
Sujet CREF:	Allergie et immunopathologie
	Rhumatologie
	Immunologie
Mots-clés:	Ankylosing spondylitis
	Anti-TNF
	Infliximab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0392-856X
	info:scp/84963818158